Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
Ginkgo Bioworks Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2021 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : May 11, 2021 SOARING EAGLE ACQUISITION CORP. Cayman Islands 001-40097 N/A 955 Fifth Avenue 10075 Registrant's telephone number, including area code: 209-7280 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communic...",
"Merger Agreement, by and among Soaring Eagle Acquisition Corp., SRNG Merger Sub Inc. and Ginkgo Bioworks, Inc.†",
"Form of Subscription Agreement",
"Form of Amended and Restated Registration Rights Agreement",
"Company Stockholder Support Agreement, by and among Soaring Eagle Acquisition Corp., SRNG Merger Sub Inc. and certain Supporting Stockholders of Ginkgo Bioworks, Inc",
"Sponsor Support Agreement, by and among Eagle Equity Partners III, LLC, Ginkgo Bioworks, Inc., Soaring Eagle Acquisition Corp. and certain of its shareholders",
"Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming",
"Investor Presentation, dated May 2021",
"Summary Risk Factors" |
|
|
|